Brief: Lumos Pharma Reports Qtrly Loss Per Share Of $1.04
05/05/2021 21:54
May 5 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES CLINICAL AND CORPORATE UPDATES
* QTRLY LOSS PER SHARE $1.04
* Q1 EARNINGS PER SHARE VIEW $-0.87 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7l15Jz
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)